GNPDA1 is an enzyme that plays a pivotal role in amino sugar metabolism by catalyzing the deamination of glucosamine-6-phosphate. Its activity can be enhanced by compounds that increase the availability of its substrate or allosterically modulate its function. For instance, the enhancement of the metabolic flux through the glycolytic pathway increases the pool of glucose 6-phosphate, which is a well-established allosteric activator of GNPDA1. This can be achieved through the action of certain metabolites that serve as glycolytic intermediates, thereby providing a surplus of the enzyme's substrate. Additionally, compounds that can be phosphorylated to mimic glucose 6-phosphate may also play a role in modulating GNPDA1 activity by influencing the enzyme's substrate specificity or by competing with natural substrates, thus affecting its enzymatic kinetics.
Moreover, the activation of cellular energy sensors such as AMP-activated protein kinase (AMPK) induces a cascade of metabolic alterations that can indirectly stimulate GNPDA1 activity. This is particularly evident with compounds that serve as analogs of AMP or activate AMPK, leading to increased cellular uptake of glucose and subsequent augmentation of glucose 6-phosphate concentrations. Furthermore, certain compounds that increase intracellular levels of cyclic AMP (cAMP) can potentiate GNPDA1 activity by enhancing the allosteric effects conferred by glucose 6-phosphate. This indicates that the regulation of GNPDA1 is closely intertwined with the cell's metabolic state, and its activity can be modulated by a diverse array of compounds that influence the broader metabolic network within which GNPDA1 operates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMP analog that activates AMPK, leading to metabolic pathway alterations that can increase glucose uptake and subsequent glucose 6-phosphate availability for GNPDA1 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP by preventing its breakdown, potentially enhancing GNPDA1 activity through allosteric modulation by glucose 6-phosphate. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
Precursor of NAD+ which can influence energy metabolism and may alter the availability of substrates such as fructose 6-phosphate, which can modulate GNPDA1 activity. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activates AMPK, which can lead to metabolic changes increasing glucose uptake and glucose 6-phosphate concentration, indirectly activating GNPDA1. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Donates electrons in redox reactions, potentially affecting the pentose phosphate pathway and increasing the pool of glucose 6-phosphate that allosterically activates GNPDA1. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Can be phosphorylated to produce glucosamine 6-phosphate, the substrate of GNPDA1, thus increasing its enzymatic activity. | ||||||
Pyruvic acid | 127-17-3 | sc-208191 sc-208191A | 25 g 100 g | $41.00 $96.00 | ||
Metabolite that can enhance glycolytic flux, potentially increasing the level of glucose 6-phosphate and activating GNPDA1. | ||||||
AICA-Riboside, 5′-Phosphate | 3031-94-5 | sc-202448B sc-202448C sc-202448 sc-202448A | 5 mg 10 mg 50 mg 100 mg | $184.00 $281.00 $505.00 $938.00 | 1 | |
An AMP analog that can activate AMPK, leading to increased glucose uptake and availability of GNPDA1 substrates. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Mimics glucose and can be phosphorylated to 2-deoxy-D-glucose-6-phosphate, which may compete with glucose 6-phosphate and indirectly affect GNPDA1 activity. | ||||||
Phenformin Hydrochloride | 834-28-6 | sc-219590 | 10 g | $119.00 | 4 | |
Activates AMPK, altering metabolic pathways to increase glucose uptake and glucose 6-phosphate levels, indirectly activating GNPDA1. | ||||||